New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases

A paper published today, " Financing translation: Analysis of the NCATS rare-diseases portfolio " in Science Translational Medicine, demonstrates the potential of a new financing technique to reduce the risk associated with investing in the treatment of new diseases and potentially unlock new levels of funding for developing so-called "orphan" drugs.

http://ift.tt/1wrDGgL